COMMUNIQUÉS West-GlobeNewswire

-
KFSHRC First in the Middle East to Implant AI-Powered Brain-Sensing Device for Treating Neurological Disorders
11/06/2025 -
AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical’s SCD Therapy to Advance Breakthrough Burn and Sepsis Research
11/06/2025 -
IntelGenx Announces Rebranding to Nualtis, Signaling Strategic Evolution and Renewed Vision
11/06/2025 -
Artelo Biosciences Announces Reverse Stock Split
11/06/2025 -
OKYO Pharma to Present at the Bio International Convention
11/06/2025 -
Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada
11/06/2025 -
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing
11/06/2025 -
GraceMed announces appointment of Dan Pawliw as Chief Executive Officer
11/06/2025 -
Veru to Participate in the Virtual BTIG Obesity Health Forum
11/06/2025 -
Lisata Therapeutics to Present at the 2025 BIO International Convention
11/06/2025 -
Windtree Receives Offer for Its Preclinical Oncology Drug Candidate
11/06/2025 -
Management Confidence: Shineco Executives Launch up to $2M Open-Market Stock Purchase Program
11/06/2025 -
Precision Neuroscience Expands Leadership Team With Key Hires From Meta and FDA
11/06/2025 -
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears
11/06/2025 -
Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress
11/06/2025 -
Femasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations
11/06/2025 -
Project 55 Launches Free Mental Health First Responder Training for Public Use
11/06/2025 -
Moleculin Participates in Virtual Investor “What This Means” Segment
11/06/2025 -
Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program
11/06/2025
Pages